| TRVN Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the TRVN shares outstanding history going back to 11/19/2013:
Also see: TRVN Market Cap History TRVN YTD Return |
TRVN Shares Outstanding History — Trevena Share Count Over Time
As of 8/6/2024 Trevena has 852933 TRVN shares outstanding. Investors often track the TRVN shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows TRVN share count trends over time, with 43 historical shares outstanding datapoints presented, dating back to 11/19/2013.
| TRVN Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TRVN Historical Shares Outstanding: +34.43% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TRVN Stock Price Chart |
| About Trevena Inc |
| Trevena is a biopharmaceutical company. Co.'s primary product, OLINVYK™ (oliceridine) injection, is an opioid agonist for use in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. Co.'s product candidates include: TRV250, which is a G-protein biased delta-opioid receptor agonist as a compound with a mechanism for the treatment of acute migraine; TRV045, which is Co.'s sphingosine-1-phosphate receptor modulator that may provide a non-opioid approach to managing chronic pain; as well as TRV734, a new chemical entity targeting the same mechanism of action at the mu opioid receptor as OLINVYK. We show 43 historical shares outstanding datapoints in our coverage of TRVN's shares outstanding history. Understanding the changing numbers of TRVN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like TRVN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching TRVN by allowing them to research TRVN shares outstanding history as well as any other stock in our coverage universe. |
| TRVN Current Stock Quote |
Quotes delayed 20 minutes  Free TRVN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| TRVN Share Performance |
| Shares Outstanding Peers |
| Trevena (TRVN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
TSBX Shares Outstanding History TSHA Shares Outstanding History TSRO Shares Outstanding History TSVT Shares Outstanding History TTNP Shares Outstanding History TTOO Shares Outstanding History TTPH Shares Outstanding History TVRD Shares Outstanding History TVTX Shares Outstanding History TVTY Shares Outstanding History More Healthcare companies » |
TRVN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
